Literature DB >> 11601742

Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis.

S S Lok1, J P Stewart, B G Kelly, P S Hasleton, J J Egan.   

Abstract

Both Epstein-Barr virus (EBV) and p53 have independently been associated with idiopathic pulmonary fibrosis (IPF). This study explores further whether a relationship potentially exists between EBV and p53 in IPF, thereby providing a possible mechanism for the role of EBV in the disease progression of IPF. Lung tissue from open lung biopsies of 14 IPF patients was compared with a control group of 19 patients. EBV status was determined using both immunohistochemistry and PCR, while p53 expression was assessed with immunohistochemistry Seven of 14 IPF patients expressed p53 compared to one of 19 control subjects (P = 0.011). Eight IPF patients and no controls were positive for EBV (P < 0.01). Four IPF patients demonstrated both EBVand p53 expression compared with no controls, (P = 0.05). This study suggests that a relationship between EBV and p53 may exist in patients with IPF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601742     DOI: 10.1053/rmed.2001.1152

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  14 in total

Review 1.  Role of innate immune system in systemic sclerosis.

Authors:  Nicola Fullard; Steven O'Reilly
Journal:  Semin Immunopathol       Date:  2015-07-10       Impact factor: 9.623

Review 2.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 4.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.

Authors:  Qiang Ding; Tracy Luckhardt; Louise Hecker; Yong Zhou; Gang Liu; Veena B Antony; Joao deAndrade; Victor J Thannickal
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

5.  Latent herpesvirus infection augments experimental pulmonary fibrosis.

Authors:  Kevin M Vannella; Tracy R Luckhardt; Carol A Wilke; Linda F van Dyk; Galen B Toews; Bethany B Moore
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

Review 6.  Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation.

Authors:  Tracy Raymond; Matthew Schaller; Cory M Hogaboam; Nicholas W Lukacs; Rosemary Rochford; Steven L Kunkel
Journal:  Proc Am Thorac Soc       Date:  2007-12

Review 7.  Determinants of initiation and progression of idiopathic pulmonary fibrosis.

Authors:  Robert Matthew Kottmann; Christopher M Hogan; Richard P Phipps; Patricia J Sime
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

8.  Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus.

Authors:  Tracy R McMillan; Bethany B Moore; Jason B Weinberg; Kevin M Vannella; W Brad Fields; Paul J Christensen; Linda F van Dyk; Galen B Toews
Journal:  Am J Respir Crit Care Med       Date:  2008-01-10       Impact factor: 21.405

9.  TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis.

Authors:  Tracy R Luckhardt; Stephanie M Coomes; Glenda Trujillo; Joshua S Stoolman; Kevin M Vannella; Urvashi Bhan; Carol A Wilke; Thomas A Moore; Galen B Toews; Cory Hogaboam; Bethany B Moore
Journal:  Fibrogenesis Tissue Repair       Date:  2011-08-02

10.  Viruses as co-factors for the initiation or exacerbation of lung fibrosis.

Authors:  Kevin M Vannella; Bethany B Moore
Journal:  Fibrogenesis Tissue Repair       Date:  2008-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.